Clinical Trial Update: PTX-35 in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for PTX-35 in patients with advanced solid tumors; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• PTX-35 (PTX-35)

Snippet

Sponsor: Pelican Therapeutics, Inc. | Conditions: Advanced Solid Tumor | Phase 1 | Status: TERMINATED | Results posted: 2024-03-12